CD19 Antigen Occupancy on Cancer Cells with the CD19 Monoclonal Antibody Tafasitamab Improves the Activation, Antitumor Efficacy, and Safety Profile of CART19 Cell Therapy
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2362-2364
10.1182/blood-2022-158273